Literature DB >> 84705

Histocompatibility antigens as markers of abnormal iron metabolism in idiopathic hemochromatosis.

D A Lloyd, P Adams, N R Sinclair, C R Stiller, L S Valberg.   

Abstract

To determine the frequency of HLA histocompatibility antigens in persons with idiopathic hemochromatosis and their usefulness as genetic markers of the disease, HLA typing for the A, B and C loci was carried out. HLA-A3 was found in 61% of 18 unrelated individuals with idiopathic hemochromatosis compared with 25% of 253 randomly chosen control subjects (P less than 0.001), and HLA-B7 was found in 50% and 22% respectively (P less than 0.025). Eighty-six members of seven families with idiopathic hemochromatosis were screened for abnormalities in iron metabolism with tests for serum iron concentration, transferrin saturation, serum ferritin concentration and iron content of the hepatocytes. Of the 14 persons selected for liver biopsy because of abnormalities detected by these tests, 8 had increased amounts of stainable iron in the hepatocytes. Body iron overload was subsequently demonstrated in six of the seven, who had undergone repeated phlebotomy. In sibships having one member with hemochromatosis, only 1 of 22 members had two haplotypes in common with the proband, whereas in sibships having more than 1 member with the disease 4 of 5 affected members had two haplotypes in common. HLA typing in families with hemochromatosis may provide a means of identifying persons at risk of acquiring the disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 84705      PMCID: PMC1819054     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  24 in total

Review 1.  Ferritin in serum. Clinical and biochemical implications.

Authors:  A Jacobs; M Worwood
Journal:  N Engl J Med       Date:  1975-05-01       Impact factor: 91.245

2.  Letter: Hemochromatosis.

Authors:  L W Powell; H M Lloyd
Journal:  Arch Intern Med       Date:  1975-09

3.  A familial study in idiopathic hemochromatosis.

Authors:  T H BOTHWELL; I COHEN; O L ABRAHAMS; S M PEROLD
Journal:  Am J Med       Date:  1959-11       Impact factor: 4.965

4.  Familial aspects of idiopathic hemochromatosis.

Authors:  G B JOHNSON; W G FREY
Journal:  JAMA       Date:  1962-03-10       Impact factor: 56.272

5.  Letter: HLA antigens in haemochromatosis.

Authors:  W G Shewan; S A Mouat; T M Allan
Journal:  Br Med J       Date:  1976-01-31

6.  Letter: HLA antigens in haemochromatosis.

Authors:  J M Walters; D W Watt; F M Stevens; C F McCarthy
Journal:  Br Med J       Date:  1975-11-29

7.  Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis.

Authors:  M Simon; M Bourel; R Fauchet; B Genetet
Journal:  Gut       Date:  1976-05       Impact factor: 23.059

Review 8.  Hemochromatosis: the unsolved problems.

Authors:  W H Crosby
Journal:  Semin Hematol       Date:  1977-04       Impact factor: 3.851

Review 9.  Protein clinical manifestations of primary tumors of the heart.

Authors:  H O McDevitt; W F Bodmer
Journal:  Am J Med       Date:  1972-01       Impact factor: 4.965

10.  Serum ferritin and the iron status of Canadians.

Authors:  L S Valberg; J Sorbie; J Ludwig; O Pelletier
Journal:  Can Med Assoc J       Date:  1976-03-06       Impact factor: 8.262

View more
  6 in total

1.  HLA as a marker of the hemochromatosis gene in Sweden.

Authors:  B Ritter; J Säfwenberg; K S Olsson
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

2.  Mapping the locus for hereditary hemochromatosis: localization between HLA-B and HLA-A.

Authors:  C Q Edwards; L M Griffen; M M Dadone; M H Skolnick; J P Kushner
Journal:  Am J Hum Genet       Date:  1986-06       Impact factor: 11.025

Review 3.  Plasma ferritin concentrations: their clinical significance and relevance to patient care.

Authors:  L S Valberg
Journal:  Can Med Assoc J       Date:  1980-06-07       Impact factor: 8.262

4.  Idiopathic hemochromotosis and alpha-1-antitrypsin deficiency: coexistence in a family with progressive liver disease in the proband.

Authors:  S Anand; R R Schade; C Bendetti; R Kelly; B S Rabin; J Krause; T E Starzl; S Iwatsuki; D H Van Thiel
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

5.  HLA-A and -B alleles and haplotypes in hemochromatosis probands with HFE C282Y homozygosity in central Alabama.

Authors:  James C Barton; Ronald T Acton
Journal:  BMC Med Genet       Date:  2002-10-07       Impact factor: 2.103

6.  HLA haplotypes associated with hemochromatosis mutations in the Spanish population.

Authors:  Arantza Pacho; Esther Mancebo; Manuel J del Rey; Maria J Castro; Desamparados Oliver; Miguel García-Berciano; Luis González; Pablo Morales
Journal:  BMC Med Genet       Date:  2004-10-21       Impact factor: 2.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.